Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia

Medicine and Dentistry

• Acute Lymphoblastic Leukemia 30%
• Adult 15%
• Blood 15%
• Busulfan 100%
• Cell Transplantation 30%
• Cyclophosphamide 15%
• Disease Free Survival 15%
• Etoposide 7%
• Fludarabine 7%
• Follow up 7%
• Hematopoietic Cell 30%
• Melphalan 7%
• Mortality 7%
• Multivariate Analysis 7%
• Overall Survival 15%
• Patient 92%
• Relapse 15%
• Retrospective Study 15%
• Spontaneous Remission 15%
• Therapeutic Procedure 7%
• Thymocyte Antibody 7%
• Toxicity 7%
• Transplantation 7%
• Transplantation Conditioning 7%
• Tyrosine-Kinase Inhibitor 7%
• Whole Body Radiation 84%

Nursing and Health Professions

• Acute Lymphoblastic Leukemia 30%
• Cell Transplantation 30%
• Confidence Interval 7%
• Cyclophosphamide 15%
• Disease Free Survival 15%
• Donor 15%
• Follow up 7%
• Mortality 7%
• Multivariate Analysis 7%
• Overall Survival 15%
• Protein Tyrosine Kinase Inhibitor 7%
• Relapse 15%
• Remission 15%
• Sibling 15%
• Standard 7%
• Toxicity 7%
• Transplantation 7%
• Treatment Outcome 7%
• Whole Body Radiation 84%

Biochemistry, Genetics and Molecular Biology

• Busulfan 100%
• Cell Transplantation 30%
• Clofarabine 7%
• Conditioning 15%
• Cyclophosphamide 15%
• Disease Free Survival 15%
• Fludarabine 7%
• Globulin 7%
• Melphalan 7%
• Mortality 7%
• Multivariate Analysis 7%
• Overall Survival 15%
• Relapse 15%
• Tyrosine Kinase Inhibitor 7%